Weight Considerations in Pharmacotherapy for Type 2 Diabetes

<table>Practice-based approach for balancing weight loss and glycemic control (HbA1c <svg height="8.9125004" id="M3" style="vertical-align:-0.04095pt" version="1.1" viewbox="0 0 10.1 8.9125004" width="10.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,8.8)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g>
</svg>7%) in uncomplicated type 2 diabetes.</table>

Journal of Obesity

fig2

Figure 2

Figure 2: Weight Considerations in Pharmacotherapy for Type 2 Diabetes 